APOE and Alzheimer disease: The role of ApoE4 proteolysis as a possible mechanism underlying disease risk has been supported by the findings of 17–20 kDa ApoE4 fragments in the prefrontal cortex from post-mortem AD patient tissue that localize within NFTs [11–15].